newsfilter
← Latest News
GlobeNewswire·

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b study of BX004; topline results anticipated in Q1 2026Topline Phase 2